Anebulo Pharmaceuticals (ANEB) Stock Overview

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.

ANEB Stock Information

Symbol

ANEB

Address

1017 Ranch Road 620 SouthLakeway, TX 78734United States

Founded

Trading hours

Website

https://www.anebulo.com

Country

🇺🇸 United States

Phone Number

(512) 598-0931

Anebulo Pharmaceuticals (ANEB) Price Chart

Anebulo Pharmaceuticals Overview: Key Details and Summary

Stock data	2023	Change
Price	$1.40	N/A
Market Cap	$35.10M	N/A
Shares Outstanding	25.07M	7.41%
Employees	2.00	N/A
Shareholder Equity	10.60M	-29.64%

Valuation	2023	Change
P/E Ratio	-2.98	N/A
P/B Ratio	3.31	N/A

Growth	2023	Change
Return on Equity	-1.1067	N/A

Earnings	2023	Change
Revenue	$0	N/A
Earnings	-$11.73M	N/A
EPS	-0.47	N/A
Earnings Yield	-0.3357	N/A

Financial Strength	2023	Change
Total Assets	$11.67M	N/A
Cash on Hand	$11.25M	N/A
Debt to Equity	0.1008	196.37%
Current Ratio	$10.92	-64.08%